Align Technology | ALGN - Ebitda

Precio De Mercado
171.14
Cambio Diario
2.43 1.44%
Mensual
2.56%
Anual
-0.63%
Q2 Expectativa
175.19




Ebitda Cambio Fecha
3M USD 1.42B 8M 2026-03
Align Technology USD 260.87M 77.03M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bruker USD 211.6M 207.4M 2025-12
Cardinal Health USD 1.09B 109M 2026-03
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
CVS Health USD 3.74B 349M 2025-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 129M 6M 2026-03
Dexcom USD 364.5M 57.7M 2026-03
Henry Schein USD 289M 2M 2026-03
Idexx Laboratories USD 354.91M 36.56M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 76.18M 28.03M 2026-03
IQVIA Holdings USD 932M 114M 2026-03
Masimo USD 91.9M 19.9M 2025-09
McKesson USD 1.68B 418M 2025-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Revvity USD 272.91M 24M 2026-03
Solventum Corp USD 437M 38M 2025-12
Stryker USD 1.57B 618M 2026-03
Teleflex USD -328.81M 536.43M 2025-09
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Veeva Systems USD 374.79M 3.96M 2025-12
Waters USD 380.97M 85.83M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12
Zoetis USD 1.04B 87M 2025-09